MedPath

Randomized, exploratory comparative study to investigate the effect of two different vocal fold augmentation materials on voice quality in unilateral vocal fold paresis.

Phase 1
Recruiting
Conditions
J38.01
Registration Number
DRKS00024026
Lead Sponsor
niversitätsklinikum Köln
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
24
Inclusion Criteria

Patients aged 18 to 80 years with symptomatic unilateral vocal fold paresis without sufficient improvement under conservative therapy for more than six months, in whom in principle both methods of vocal fold augmentation (autologous fat or aquamide) can be used, are eligible for inclusion.

Exclusion Criteria

- Incorrect or incomplete documentation
- Previous laryngeal surgery with the exception of previous augmentation with absorbable material (hyaluron)
- Laryngeal carcinoma
- Pulmonary diseases

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in subjective self-assessment of voice, 3,6 and 12 months after surgery, by questionnaire (VHI-30).
Secondary Outcome Measures
NameTimeMethod
Postoperative change in external evaluation of voice quality (HIRANO-score) over time.
© Copyright 2025. All Rights Reserved by MedPath